Over the last 25 years, MedStars has specialized in starting and developing disruptive life sciences companies with new innovative and revolutionary products. Our markets include medical devices, healthcare information systems, health related consumer products and biotechnology. We also have worked with some of the leading medical and biotech companies to help them develop and launch their own breakthrough products.
Dear Anne, as a co-founder of VISICU, working with you during the early days of our company was both rewarding and enjoyable. Your health care experience and advice were extremely helpful as we planned our strategy and your contacts during the road show prior to our IPO were also beneficial.
— Brian Rosenfeld, VISICU Co-founder, acquired by Philips
Shortly after Masimo was started in 1987, Anne DeGheest was an advisor to the founder and CEO of Masimo regarding business model and marketing strategy for this second generation pulse oximetry. Masimo went public in 2007 (NASDAQ: MASI) and has estimated revenues over $300 million in 2009
Considered one of the early founders of the DNA chip industry, Dr. Molinari consulted with Affymetrix just after it was formed from Affymax, and wrote its first marketing plan for DNA chip use in diagnostics and infectious disease. He later assisted the company in developing enforcement strategies for its DNA chip IP, and was instrumental in defending its patent claims against a large competitor.
During the time period that we were trying to raise startup funding for VISICU, Anne provided advice and encouragement, and introduced us to multiple people that helped us refine our business model. She was generous with her time and friendship. We will always look back fondly at that time, and Anne was an important part of the experience.
— Mike Breslow, VISICU Co-founder, acquired by Philips
Anne's knowledge of how the game is played, her professional relationships, instincts, and her mentoring have proved to be most helpful to me as CEO of Pixel Optics. She played a critical role in helping the company's get its initial funding and was a value-add board member.
— Ron Blum, CEO, Pixel Optics Inc.
Anne has a unique ability to identify and quantify high potential market segments for medical devices.
— Robert Behl, Serial Entrepreneur (multiple medical device companies)
It's one thing to get an investment. What we are getting from Anne DeGheest of MedStars is far more significant. As an investor and Board member of our start-up, Catheter Connections, Anne is providing not just practical advice, but also the guidance and mentoring on how to best implement the advice. That is invaluable.
— Vicki E. Farrar, CEO, Catheter Connections, Inc.
Anne has been a very valuable extended member of our team as we have navigated through the challenges of developing our initial business plan, pursuing and securing funding, developing our customer acquisition, regulatory and reimbursement strategies and adjusting our plans in response to customer/market feedback. Her knowledge, experience, network of contacts and direct input along the way, have been very beneficial to me and the Company.
— Dan Eckert, CEO, PolyRemedy, Inc.
Anne and I helped spin out a biotech company in Belgium which went on to be the keystone to a California company. She is a great big thinker, and facilitator. I enjoyed working with her very much.
— Nola E Masterson, Managing Director, Science Futures
Our relationship with Anne from Medstars allowed Textronics to access an expert network in the Bay Area of seasoned medical sector investors and entrepreneurs. It was a valuable and highly credible affiliation that aided in establishing our technology in the commercial market.
— Stacey Burr, CEO, Textronics Inc., acquired by Adidas.
Working with Bob Molinari on establishing operations, sales and marketing at a start up Biotech Company was one of the most exciting ventures in my career. His enthusiasm, creativity knowledge and ability to relate to people made all the difference in the early stages of company development. Bob also has the contacts and skills to bring in good people and promote a sense of purpose and direction to the company. His ability to relate the strength of the technology to the value of business plan is critical in getting quality investors onboard.
— Joseph D. Kittle, Jr, Ph.D., Chairman, Synthetic Biology Industry Association and Principle Virtual 3C Consulting
Working with Bob at Medstars put PharmaSecure on the track to success. Bob provides timely, relevant guidance informed by years of experience within industry -- thank you, Bob, for your continued support!
— Sarah Hine, CEO, PharmaSecure, Inc.
I've worked with Bob for what must be two decades now, and his passion for commercializing very early stage biotechnology remains undiminished. His success record is also pretty enviable.
— Charles R. Cantor, CSO and Co-founder of Sequenom, member of the National Academy of Sciences, co-founder of the US Human Genome project.
Over the years, we have found MedStars and Anne DeGheest to be an insightful, courageous and very competent executive and investor. It is a pleasure to work with Anne and Medstars.
— Howard D. Palefsky, Managing Director, Montreux Equity Partners
Anne is brilliant. She has a keen mind and is able to understand a medical product's real niche as well as the issues it will face in product adoption. I have referred entrepreneurs and young companies to Anne because she is able to unearth the gem from a product concept that is not yet fully developed.
— J. Casey McGlynn, Chairman of the Life Sciences Group at Wilson Sonsini Goodrich & Rosati
In working with Anne through Life Science Angels, it is clear she possesses a valuable combination of exceptional analytical skills with hands-on experience. Anne provides direct, clear and actionable advice that enables entrepreneurs to best maximize their chances for a successful outcome.